The prognostic use of right heart catheterization data in patients with advanced heart failure: How relevant are invasive procedures in the risk stratification of advanced heart failure in the era of neurohormones?

Journal of Heart and Lung Transplantation

Volumn 24, Issue 3, 2005, Pages 303-309

  Gardner, R S ^a,b   Henderson, G ^a   McDonagh, T A ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEART CATHETERIZATION; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HEART TRANSPLANTATION; HUMAN; LUNG ARTERY PRESSURE; LUNG WEDGE PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIVARIATE ANALYSIS OF VARIANCE; NON INVASIVE MEASUREMENT; PATIENT REFERRAL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE;

EID: 14644401083     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.01.010     Document Type: Article

References (23)

1. Griffin B.P., Shah P.K., Ferguson J., et al. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or dilated cardiomyopathy. Am J Cardiol. 67:1991;848-853
2. Warner Stevenson L., Tillisch J.H., Hamilton M., et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction <20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol. 66:1990;1348-1354
3. Keogh A.M., Baron D.W., Hickie J.B. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol. 65:1990;903-908
4. Morley D., Brozena S. Assessing risk by hemodynamic profile in patients awaiting cardiac transplantation. Am J Cardiol. 73:1994;379-383
5. Komajda M., Jais P., Reeves F., et al. Factors predicting mortality in idiopathic dilated cardiomyopathy. Eur Heart J. 11:1990;824-831
6. Saxon L.A., Stevenson W.G., Middlekauff H.R., et al. Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 72:1993;62-65
7. Gardner R.S., Ozalp F., Murday A.J., et al. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J. 24:2003;1735-1743
8. Aaronson K.D., Schwartz J.S., Chen T.M., et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 95:1997;2660-2667
9. Packer M., Coats A.J., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 344:2001;1651-1658
10. McMurray J.J., Ostergren J., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors the CHARM-Added trial. Lancet. 362:2003;767-771
11. McDonagh T.A., Cunningham A.D., Morrison C.E., et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart. 86:2001;21-26
12. Hülsmann M., Berger R., Sturm B., et al. Prediction of outcome by neurohumoral activation, the six-minute walk test and the Minnesota Living With Heart Failure Questionnaire in an outpatient cohort with congestive heart failure. Eur Heart J. 23:2002;886-891
13. Tsutamoto T., Wada A., Maeda K., et al. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Eur Heart J. 20:1999;1799-1807
14. Gore J.M., Goldberg R.J., Spodick D.H., et al. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest. 92:1987;721-727
15. Zion M.M., Balkin J., Rosenmann D., et al. Use of pulmonary artery catheters in patients with acute myocardial infarction analysis of experience in 5,841 patients in the SPRINT Registry. Chest. 98:1990;1331-1335
16. Connors A.F. Jr, Speroff T., Dawson N.V., et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 276:1996;889-897
17. Kirklin J.K., Naftel D.C., Kirklin J.W., et al. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Lung Transplant. 7:1988;331-336
18. Erickson K.W., Constanzo-Nordin M.R., O'Sullivan E.J., et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Lung Transplant. 9:1990;526-537
19. Hosenpud J.D., Bennet L.E., Keck B.M., et al. ISHLT Registry Report: the Registry of the International Society for Heart and Lung Transplantation: seventeenth official report - 2000. J Heart Lung Transplant. 19:2000;909-931
20. Bourge R.C., Kirklin J.K., Naftel D.C., et al. Predicting outcome after cardiac transplantations lessons from the Cardiac Transplant Research Database. Curr Opin Cardiol. 12:1997;136-145
21. McCarthy J.F., McCarthy P.M., Massad M.G., et al. Risk factors for death after heart transplantation does a single-centre experience correlate with multicentre registries? Ann Thorac Surg. 65:1998;1574-1579
22. Braunschweig F., Linde C., Eriksson M.J., et al. Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J. 23:2002;59-69
23. Adamson P.B., Magalski A., Braunschweig F., et al. Ongoing right ventricular hemodynamics in heart failure clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol. 41:2003;565-571